NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Lipidor AB (publ) (ST: LIPI)

 
LIPI Technical Analysis
5
As on 9th Jun 2023 LIPI SHARE Price closed @ 1.49 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.08 & Strong Sell for SHORT-TERM with Stoploss of 7.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

LIPISHARE Price

Open 1.84 Change Price %
High 2.30 1 Day -0.20 -11.83
Low 1.49 1 Week 0.77 106.94
Close 1.49 1 Month 0.93 166.07
Volume 824366 1 Year -6.99 -82.43
52 Week High 9.22 | 52 Week Low 0.43
 
ST Sweden Most Active Stocks
QUIA 0.02 0.00%
QLIFE 0.04 0.00%
SBB-B 5.38 3.07%
STRLNG 0.12 33.33%
LUNE 21.97 6.65%
SAS 0.36 5.88%
URBIT 0.02 0.00%
IDOGEN 0.15 -31.82%
STAR-B 0.89 -1.11%
TELIA 24.60 0.41%
 
ST Sweden Top Gainers Stocks
S2M 0.52 100.00%
NETM-B 1.35 42.11%
STRLNG 0.12 33.33%
IVACC 7.26 32.97%
SPRINT 0.63 16.67%
TH1NG 1.61 16.67%
ATIC 5.14 15.77%
ATIC 5.14 15.77%
CIRCHE 3.69 15.67%
AXIC-A 8.16 15.25%
 
ST Sweden Top Losers Stocks
IDOGEN 0.15 -31.82%
IMMU 0.72 -27.27%
ALLR 1.55 -26.54%
MIDW-A 24.80 -22.98%
KILI 0.76 -16.48%
FRACTL 36.80 -14.02%
DIVIO-B 0.13 -13.33%
ZZ-B 41.50 -12.08%
LIPI 1.49 -11.83%
BACTI-B 72.70 -10.69%
 
 
LIPI
Daily Charts
LIPI
Intraday Charts
Whats New @
Bazaartrend
LIPI
Free Analysis
 
LIPI Important Levels Intraday
RESISTANCE3.05
RESISTANCE2.55
RESISTANCE2.24
RESISTANCE1.93
SUPPORT1.05
SUPPORT0.74
SUPPORT0.43
SUPPORT-0.07
 
LIPI Forecast April 2024
4th UP Forecast5.52
3rd UP Forecast4.23
2nd UP Forecast3.43
1st UP Forecast2.63
1st DOWN Forecast0.35
2nd DOWN Forecast-0.45
3rd DOWN Forecast-1.25
4th DOWN Forecast-2.54
 
LIPI Weekly Forecast
4th UP Forecast2.99
3rd UP Forecast2.51
2nd UP Forecast2.21
1st UP Forecast1.92
1st DOWN Forecast1.06
2nd DOWN Forecast0.77
3rd DOWN Forecast0.47
4th DOWN Forecast-0.01
 
LIPI Forecast2024
4th UP Forecast18.83
3rd UP Forecast13.27
2nd UP Forecast9.83
1st UP Forecast6.4
1st DOWN Forecast-3.42
2nd DOWN Forecast-6.85
3rd DOWN Forecast-10.29
4th DOWN Forecast-15.85
 
 
LIPI Other Details
Segment EQ
Market Capital 278178240.00
Sector Healthcare
Industry Drug Manufacturers-General
Offical website >
 
LIPI Address
LIPI
 
LIPI Latest News
 
Your Comments and Response on Lipidor AB (publ)
 
LIPI Business Profile
Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, and AKP-03 AKP-07 for eczema. It offers active pharmaceutical ingredients used in products for various therapeutic applications, such as anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine. The company also develops a range of spray products for animal skin care in dogs, cats, and horses; and consumer health care products for applications, including antibacterial, antiseptic, moisturizing emollient, disinfectant, and acne and wart treatment. The company has a collaboration agreement with Cannassure Therapeutics Ltd. for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. Lipidor AB (publ) was founded in 2009 and is based in Stockholm, Sweden. Address: MMK, Stockholm University, Stockholm, Sweden, 106 91
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service